Literature DB >> 10435562

Postatrophic hyperplasia of the prostate gland: a detailed analysis of its morphology in needle biopsy specimens.

M B Amin1, P Tamboli, M Varma, J R Srigley.   

Abstract

Postatrophic hyperplasia is a histologic pattern showing atrophic and hyperplastic glands, sometimes with a small acinar configuration. Because distinction from small acinar carcinoma may be challenging, particularly in needle biopsy specimens, we studied 56 needle biopsy specimens containing 68 foci to ascertain the morphologic spectrum of postatrophic hyperplasia. All foci showed a distinct lobular small acinar proliferation with varying proportions of atrophic and hyperplastic glands. Gland size was typically variable, predominantly of small caliber but occasionally of intermediate to larger caliber. Round, oval, elongated, slitlike and stellate glands were seen. The nuclei were generally regular without hyperchromasia, with rare small nucleoli seen in 10 (15%) foci. The cytoplasm was variable, ranging from scant in atrophic glands to moderate or abundant and clear or occasionally eosinophilic in hyperplastic glands. An irregular internal gland contour was noted in glands with features of both atrophy and hyperplasia. Basal cells were apparent by light microscopy in most foci, although their distribution within foci and between foci varied. This finding was confirmed in all 26 cases studied with the high molecular weight cytokeratin immunohistochemical stain (34betaE12). Associated pathology included adenocarcinoma (12%), high-grade prostatic intraepithelial neoplasia (3%), atrophy distinct from foci of postatrophic hyperplasia (55%), and atypical adenomatous hyperplasia (2%). Adjunctive features of cancer were not seen in any of the foci of postatrophic hyperplasia. Familiarity with the histologic features of postatrophic hyperplasia will allow its confident separation from cancer, especially in limited biopsy material.

Entities:  

Mesh:

Year:  1999        PMID: 10435562     DOI: 10.1097/00000478-199908000-00010

Source DB:  PubMed          Journal:  Am J Surg Pathol        ISSN: 0147-5185            Impact factor:   6.394


  7 in total

1.  Immunohistochemical application of D2-40 as basal cell marker in evaluating atypical small acinar proliferation of initial routine prostatic needle biopsy materials.

Authors:  Naoto Kuroda; Kazunobu Katto; Masato Tamura; Tomoyuki Shiotsu; Shoichiro Nakamura; Yuji Ohtsuki; Ondrej Hes; Michal Michal; Kaori Inoue; Masahiko Ohara; Keiko Mizuno; Gang-Hong Lee
Journal:  Med Mol Morphol       Date:  2010-09-21       Impact factor: 2.309

2.  Proliferative lesions of prostate: a multivariate approach to differential diagnosis.

Authors:  Fernanda de Barros Correia Cavalcanti; Venâncio Avancini Ferreira Alves; Julio Pereira; Cristina T Kanamura; Alda Wakamatsu; Luís Balthazar Saldanha
Journal:  Pathol Oncol Res       Date:  2005-07-01       Impact factor: 3.201

3.  Acquired cystic disease-associated renal cell carcinoma: an immunohistochemical and fluorescence in situ hybridization study.

Authors:  Naoto Kuroda; Motoki Yamashita; Yoshiyuki Kakehi; Ondrej Hes; Michal Michal; Gang-Hong Lee
Journal:  Med Mol Morphol       Date:  2011-12-17       Impact factor: 2.309

4.  Diagnostic Value of Cytokeratin 34 beta E12 (Ck34βE12) and α-Methylacyl-CoA racemase (AMACR) Immunohistochemical Expression in Prostatic Lesions.

Authors:  Ikram A Hasan; Hiba Ahmed Gaidan; Methaq Mueen Al-Kaabi
Journal:  Iran J Pathol       Date:  2020-05-21

5.  Prostatic atrophy: evidence for a possible role of local ischemia in its pathogenesis.

Authors:  Luciana R Meirelles; Athanase Billis; Ana C S Cotta; Rui T Nakamura; Nelson M G Caserta; Adilson Prando
Journal:  Int Urol Nephrol       Date:  2002       Impact factor: 2.370

6.  Diagnostic utility of α-methylacyl CoA racemase (P504S) & HMWCK in morphologically difficult prostate cancer.

Authors:  K Kumaresan; Nandita Kakkar; Alka Verma; Arup Kumar Mandal; Shrawan Kumar Singh; Kusum Joshi
Journal:  Diagn Pathol       Date:  2010-12-22       Impact factor: 2.644

7.  p63 is more sensitive and specific than 34βE12 to differentiate adenocarcinoma of prostate from cancer mimickers.

Authors:  Mahmoud Reza Kalantari; Kazem Anvari; Hasan Jabbari; Fatemeh Varshoee Tabrizi
Journal:  Iran J Basic Med Sci       Date:  2014-07       Impact factor: 2.699

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.